104 related articles for article (PubMed ID: 38762907)
1. Erythrocyte membrane-camouflaged mesoporous silica composite nanoparticles for loading and controlled release of the hepatoprotective agent silibinin: A-synthesis and physicochemical characterization.
Tayebi Khorrami V; Raee MJ; Abolmaali SS; Abedanzadeh M; Shafiee M; Tamaddon AM
J Pharm Pharmacol; 2024 May; ():. PubMed ID: 38762907
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Pore-Size-Tunable Mesoporous Silica Nanoparticles by Simultaneous Sol-Gel and Radical Polymerization to Enhance Silibinin Dissolution.
Shafiee M; Abolmaali S; Abedanzadeh M; Abedi M; Tamaddon A
Iran J Med Sci; 2021 Nov; 46(6):475-486. PubMed ID: 34840388
[TBL] [Abstract][Full Text] [Related]
3. Pre-treatment With PLGA/Silibinin Nanoparticles Mitigates Dacarbazine-Induced Hepatotoxicity.
Durymanov M; Permyakova A; Reineke J
Front Bioeng Biotechnol; 2020; 8():495. PubMed ID: 32671024
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte-cancer Hybrid Membrane-camouflaged Mesoporous Silica Nanoparticles Loaded with Gboxin for Glioma-targeting Therapy.
Jiao X; Yu X; Gong C; Zhu H; Zhang B; Wang R; Yuan Y
Curr Pharm Biotechnol; 2022; 23(6):835-846. PubMed ID: 34825635
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin.
Raghu R; Karthikeyan S
Environ Toxicol Pharmacol; 2016 Sep; 46():217-226. PubMed ID: 27497728
[TBL] [Abstract][Full Text] [Related]
6. Silibinin alleviates N-nitrosodimethylamine-induced glutathione dysregulation and hepatotoxicity in rats.
Ezhilarasan D; Karthikeyan S
Chin J Nat Med; 2016 Jan; 14(1):40-7. PubMed ID: 26850345
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
Xia Q; Zhang Y; Li Z; Hou X; Feng N
Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats.
Ezhilarasan D; Karthikeyan S; Vivekanandan P
Environ Toxicol Pharmacol; 2012 Nov; 34(3):1004-13. PubMed ID: 22986105
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.
Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
Theranostics; 2017; 7(3):523-537. PubMed ID: 28255347
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies.
Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926
[TBL] [Abstract][Full Text] [Related]
11. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of tamoxifen loaded silica and NH2 functionalized mesoporous silica nanoparticles as delivery systems against MCF-7 breast cancer cells.
Taghavi S; Shahnani M; Rafati H
Iran J Basic Med Sci; 2023; 26(11):1334-1341. PubMed ID: 37885996
[TBL] [Abstract][Full Text] [Related]
13. Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.
Ezhilarasan D; Evraerts J; Brice S; Buc-Calderon P; Karthikeyan S; Sokal E; Najimi M
J Clin Exp Hepatol; 2016 Sep; 6(3):167-174. PubMed ID: 27746612
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Mesoporous Silica Nanoparticles for Enhanced Blood Circulation and Cancer Therapy.
Peng H; Xu Z; Wang Y; Feng N; Yang W; Tang J
ACS Appl Bio Mater; 2020 Nov; 3(11):7849-7857. PubMed ID: 35019525
[TBL] [Abstract][Full Text] [Related]
15. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation.
Singh AK; Singh SS; Rathore AS; Singh SP; Mishra G; Awasthi R; Mishra SK; Gautam V; Singh SK
ACS Biomater Sci Eng; 2021 Aug; 7(8):3737-3753. PubMed ID: 34297529
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
Ghahfarokhi MR; Dini G; Movahedi B
Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of silica-coated insulin-loaded chitosan nanoparticles as a promising oral administration system.
Fathy MM; Hassan AA; Elsayed AA; Fahmy HM
BMC Pharmacol Toxicol; 2023 Mar; 24(1):21. PubMed ID: 36998008
[TBL] [Abstract][Full Text] [Related]
18.
Kumar H; Pani B; Kumar J; Kumar P
Curr Pharm Biotechnol; 2023; 24(10):1297-1306. PubMed ID: 37254276
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.
Mohseni M; Gilani K; Mortazavi SA
Iran J Pharm Res; 2015; 14(1):27-34. PubMed ID: 25561909
[TBL] [Abstract][Full Text] [Related]
20. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
